Editorial Bioteck

23 March 2026

The safety of Bioteck products: validation of the Zymo-Teck® process for inactivating the viral load on biomaterials

We present a unique study, published in 2016 in the Journal of Virological Methods, which evaluated the effectiveness of the Bioteck production process in inactivating viral load on bone substitutes and membranes of equine origin.

 

The research analyzed the various steps of the Zymo-Teck® deantigenation process, demonstrating their ability to reduce and inactivate potential viral agents.

 

The results indicate that the Bioteck production process guarantees safe biomaterials free of pathogenic contaminants, confirming maximum reliability for clinical use.

 

This was the first study in the world to evaluate the antiviral efficacy of an industrial process for the production of biomaterials, underlining Bioteck’s commitment to safety and innovation.

 

Click here to read the full article
or download the Bioteck Academy leaflet for a concise overview.
If you’d like to learn more about the Zymo-Teck process, click here!